Brief: Aurobindo Pharma Says Completion Of US FDA Inspection At Unit-V Of Unit
12/12/2025 12:33
Dec 12 (Reuters) - Aurobindo Pharma Ltd ARBN.NS: AUROBINDO PHARMA - COMPLETION OF US FDA INSPECTION AT UNIT-V OF APITORIA PHARMA PRIVATE LIMITED AUROBINDO PHARMA - A ‘FORM 483’ WAS ISSUED WITH 03 OBSERVATIONS Source text: [ID:] Further company coverage: ARBN.NS ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aurobindo Pharma
See all newsBrief: Aurobindo Pharma Gets Tax Order Confirming Total Disputed Amount 46 Million Rupees
India's Aurobindo Pharma falls after US FDA flags observation at Telangana facility
Brief: Aurobindo Pharma Says US FDA Inspected API Manufacturing Facility Of Unit Apitoria Pharma
Brief: Aurobindo Pharma Gets USFDA Final Approval For Beclomethasone Dipropionate HFA Inhalation Aerosol
Brief: Aurobindo Pharma Says US FDA Inspected Unit-IV Of Apitoria Pharma From September 7 To September 11